+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sufugolix (CAS 308831-61-0) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • November 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4186685
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Sufugolix. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Sufugolix global market report's key points:

  • Sufugolix description, applications and related patterns
  • Sufugolix market situation
  • Sufugolix manufacturers and distributors
  • Sufugolix prices
  • Sufugolix end-users
  • Sufugolix downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Sufugolix end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Sufugolix market trends and forecast, distinguish Sufugolix manufacturers and suppliers.

The sixth chapter provides Sufugolix prices data.

The seventh chapter analyses Sufugolix downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. SUFUGOLIX GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. SUFUGOLIX APPLICATIONS

3. SUFUGOLIX MANUFACTURING METHODS

4. SUFUGOLIX PATENTS

5. SUFUGOLIX MARKET WORLDWIDE
5.1. Global Sufugolix market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Sufugolix
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Sufugolix
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. SUFUGOLIX MARKET PRICES
  • Europe
  • Asia
  • North America
7. SUFUGOLIX END-USE SECTOR

Related Topics

Related Reports

Desipramine (CAS 50-47-5) Global Market Research Report 2024 - Product Image

Desipramine (CAS 50-47-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Ornidazole (CAS 16773-42-5) Global Market Research Report 2024 - Product Image

Ornidazole (CAS 16773-42-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Adenosine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Adenosine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 88 Pages
  • Global
From
Ranitidine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Ranitidine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Smart Insulin Pens Market Size, Share & Industry Trends Analysis Report By Usability, By Product, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Smart Insulin Pens Market Size, Share & Industry Trends Analysis Report By Usability, By Product, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 337 Pages
  • Global
From

About the Sufugolix Market

Sufugolix is a drug used to treat endocrine and metabolic disorders. It is a gonadotropin-releasing hormone (GnRH) antagonist, which works by blocking the action of GnRH, a hormone that stimulates the release of other hormones. This helps to reduce the production of hormones that can cause endocrine and metabolic disorders. Sufugolix is used to treat conditions such as polycystic ovary syndrome, precocious puberty, and prostate cancer. The Sufugolix market is composed of a variety of companies that develop, manufacture, and market the drug. These companies include AbbVie, Astellas Pharma, and Eisai. Other companies involved in the Sufugolix market include Daiichi Sankyo, Merck, and Pfizer. These companies are involved in the research, development, and marketing of the drug, as well as providing support services to healthcare professionals and patients. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.